[EU PEGS] Ready-to-Use Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors

[EU PEGS] Ready-to-Use Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Version:
21405

File Name/Number:
EU PEGS

Year:
2022

 

Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers.